• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL Back to Search Results
Catalog Number 221788
Device Problem Contamination of Device Ingredient or Reagent (2901)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/12/2023
Event Type  malfunction  
Manufacturer Narrative
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported when using the bd bbl¿ thioglycollate medium, enriched with vitamin k1 and hemin has been contaminated.There was no report of impact to patient or user.
 
Event Description
It was reported when using the bd bbl¿ thioglycollate medium, enriched with vitamin k1 and hemin has been contaminated.There was no report of impact to patient or user.
 
Manufacturer Narrative
H.6.Investigation summary: the release testing that is performed on this product does include media appearance.No foreign objects were observed in qc samples at the time of release.If foreign matter had been noted during qc testing, the product would have been placed on quality notification and further analysis including 100% inspection of the batch would have been conducted.The complaint history was reviewed, and there is one other complaint on batch 3025456.Retention samples (10) were available for inspection.All ten of the retention samples appeared trace hazy with particles.Two of the retention samples were reduced by boiling and allowed to cool.After cooling, the particles were no longer visible in the solution.As stated in the ifu for material 221788 (available on bd.Com/e-labeling), this media should be reduced by boiling prior to use.The two reduced retention samples were then incubated in a 20-25 degree celsius incubator (1) and a 33-37 degree celsius incubator (1).At fourteen days, there was no growth observed in the incubated retention samples.No photos were received to assist in the investigation.Five tubes were returned from batch 3025456 in a zip lock bag with padding in a box with returns for another complaint.The five tubes contained small particles.The media was not hazy.After the five returned tubes were reduced by boiling and cooled, two of the tubes contained a few particles.The media was gram stained and showed no organisms.The five tubes were incubated in a 33-37 degree celsius incubator.At seven days, no growth was observed in any of the returned tubes.This complaint can be confirmed for particles.As stated in the ifu mentioned above, this media should be reduced by boiling prior to use.No complaint trends for this defect have been identified for this product; no actions are indicated at this time.Bd will continue to trend complaints for particles.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN
Type of Device
CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
jo doyka
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key18307636
MDR Text Key330935578
Report Number1119779-2023-01337
Device Sequence Number1
Product Code JSG
UDI-Device Identifier00382902217886
UDI-Public(01)00382902217886
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K803023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 04/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date01/27/2024
Device Catalogue Number221788
Device Lot Number3025456
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/15/2023
Initial Date FDA Received12/11/2023
Supplement Dates Manufacturer Received04/23/2024
Supplement Dates FDA Received05/20/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/25/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-